Cidara Therapeutics's total assets for Q4 2024 were $214.80M, an increase of 32.32% from the previous quarter. CDTX total liabilities were $51.49M for the fiscal quarter, a 10.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.